✅ 100% Original Product
Description:
TIZARO 7.5mg/0.5ml SC Injection contains Tirzepatide 7.5 mg/0.5 mL. It is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support weight management in eligible patients.
Uses:
Type 2 diabetes mellitus
Improves blood glucose control
Helps with weight management in appropriate patients
Reduces appetite and improves metabolic control
Dose:
Usually 7.5 mg once weekly by subcutaneous injection after dose escalation, or as directed by a doctor.
Inject under the skin of the abdomen, thigh, or upper arm.
Dose adjustments should be made gradually based on response and tolerability.
Follow the prescribed schedule and do not stop without medical advice.